We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.95%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$61.1B
AUM Growth
+$4.73B
(+8.4%)
Cap. Flow
+$390M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
17.66%
Holding
2,331
New
154
Increased
918
Reduced
1,058
Closed
154
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$144M |
| 2 |
Cisco
CSCO
|
+$123M |
| 3 |
Moderna
MRNA
|
+$120M |
| 4 |
JPMorgan Chase
JPM
|
+$95.4M |
| 5 |
FedEx
FDX
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$124M |
| 2 |
Mastercard
MA
|
+$101M |
| 3 |
Home Depot
HD
|
+$95.7M |
| 4 |
Amazon
AMZN
|
+$74.1M |
| 5 |
Eli Lilly
LLY
|
+$72.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.6% |
| 2 | Consumer Discretionary | 14.64% |
| 3 | Healthcare | 14.47% |
| 4 | Industrials | 11.01% |
| 5 | Consumer Staples | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Gerdau
GGB
$9.29B
| $629K | ﹤0.01% |
148,418
-31,534
| -18% | -$119K |
|
1752
BioCryst Pharmaceuticals
BCRX
$2.68B
| $624K | ﹤0.01% |
61,386
-960
| -2% | -$9.9K |
|
|
ITCI
1753
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $624K | ﹤0.01% |
18,394
-14,441
| -44% | -$501K |
|
1754
Phreesia
PHR
$771M
| $622K | ﹤0.01% |
11,939
+1,412
| +13% | +$89K |
|
1755
Vir Biotechnology
VIR
$1.52B
| $621K | ﹤0.01% |
+12,111
| New | +$653K |
|
|
RCM
1756
DELISTED
R1 RCM Inc. Common Stock
RCM
| $616K | ﹤0.01% |
24,949
| – | – |
|
1757
Ultrapar
UGP
$6.38B
| $615K | ﹤0.01% |
161,108
-2,524
| -2% | -$10K |
|
|
LDL
1758
DELISTED
Lydall, Inc.
LDL
| $615K | ﹤0.01% |
18,213
-6,350
| -26% | -$217K |
|
1759
Quaker Houghton
KWR
$2.99B
| $614K | ﹤0.01% |
2,520
-435
| -15% | -$116K |
|
1760
Mueller Water Products
MWA
$4.11B
| $609K | ﹤0.01% |
43,848
-7,838
| -15% | -$102K |
|
|
SHOE
1761
Shoe Station Group
SHOE
$427M
| $607K | ﹤0.01% |
19,618
+8,164
| +71% | +$201K |
|
1762
Orion
OEC
$392M
| $606K | ﹤0.01% |
30,751
+1,863
| +6% | +$33.5K |
|
1763
Sysco
SYY
$40.3B
| $606K | ﹤0.01% |
7,695
-3,736
| -33% | -$290K |
|
1764
Replimune Group
REPL
$1.17B
| $605K | ﹤0.01% |
19,842
-8,562
| -30% | -$321K |
|
1765
Ethan Allen Interiors
ETD
$605M
| $604K | ﹤0.01% |
21,867
+9,660
| +79% | +$243K |
|
1766
First Commonwealth Financial
FCF
$2.18B
| $603K | ﹤0.01% |
41,967
+1,089
| +3% | +$14.5K |
|
1767
Mitek Systems
MITK
$840M
| $603K | ﹤0.01% |
41,375
| – | – |
|
1768
Granite Construction
GVA
$5.47B
| $601K | ﹤0.01% |
+14,923
| New | +$516K |
|
1769
Costamare
CMRE
$1.67B
| $599K | ﹤0.01% |
+62,292
| New | +$581K |
|
1770
IES Holdings
IESC
$15B
| $599K | ﹤0.01% |
11,889
+1,293
| +12% | +$62.2K |
|
1771
Vera Bradley
VRA
$94.1M
| $596K | ﹤0.01% |
+59,058
| New | +$556K |
|
1772
Precigen
PGEN
$2.48B
| $595K | ﹤0.01% |
+86,374
| New | +$730K |
|
|
SPNE
1773
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $592K | ﹤0.01% |
34,006
+5,619
| +20% | +$101K |
|
1774
SFL Corp
SFL
$1.52B
| $590K | ﹤0.01% |
+73,512
| New | +$544K |
|
1775
Workhorse Group
WKHS
$33.7M
| $588K | ﹤0.01% |
14
| – | – |
|
Similar funds
VGA
AQR Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, AQR Capital Management held 2,331 positions worth $61.1B, up 8.4% from $56.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
AQR Capital Management's Q1 2021 filing shows 154 new, 918 increased, 1,058 reduced and 154 closed positions. Its largest new stake was Janus Henderson: 506,382 shares worth $15.8M. The largest sale was Microsoft, an estimated $124M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q1 2021 buy was Janus Henderson: 506,382 shares worth $15.8M.
- AQR Capital Management added most to Thermo Fisher Scientific in Q1 2021, an estimated $144M increase.
- AQR Capital Management's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
- AQR Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2021, selling an estimated $39.7M.
- AQR Capital Management's ten largest holdings make up 18% of its $61.1B portfolio in Q1 2021.
- AQR Capital Management opened 154 new positions and closed 154 in Q1 2021.
- AQR Capital Management's portfolio value rose 8.4% quarter-over-quarter to $61.1B.
Based on AQR Capital Management's 13F filing for Q1 2021, filed 17 May 2021.